Diagnosing Alzheimer's Disease from Circulating Blood Leukocytes Using a Fluorescent Amyloid Probe
| Autor: | Stefanie A.G. Black, Anastasiia A. Stepanchuk, George W. Templeton, Yda Hernandez, Tomoko Ota, Shyamosree Roychoudhury, Eric E. Smith, Philip A. Barber, Zahinoor Ismail, Karyn Fischer, Angela Zwiers, Marc J. Poulin, Kaj Blennow, Henrik Zetterberg, Peter K. Stys, Shigeki Tsutsui |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Amyloid beta-Peptides General Neuroscience Brain tau Proteins General Medicine Middle Aged Peptide Fragments Psychiatry and Mental health Clinical Psychology Early Diagnosis Alzheimer Disease Disease Progression Leukocytes Mononuclear Humans Female Geriatrics and Gerontology Biomarkers Fluorescent Dyes |
| Zdroj: | Journal of Alzheimer's disease : JAD. 85(4) |
| ISSN: | 1875-8908 |
| Popis: | Background: Toxic amyloid-β (Aβ) peptides aggregate into higher molecular weight assemblies and accumulate not only in the extracellular space, but also in the walls of blood vessels in the brain, increasing their permeability, and promoting immune cell migration and activation. Given the prominent role of the immune system, phagocytic blood cells may contact pathological brain materials. Objective: To develop a novel method for early Alzheimer’s disease (AD) detection, we used blood leukocytes, that could act as “sentinels” after trafficking through the brain microvasculature, to detect pathological amyloid by labelling with a conformationally-sensitive fluorescent amyloid probe and imaging with confocal spectral microscopy. Methods: Formalin-fixed peripheral blood mononuclear cells (PBMCs) from cognitively healthy control (HC) subjects, mild cognitive impairment (MCI) and AD patients were stained with the fluorescent amyloid probe K114, and imaged. Results were validated against cerebrospinal fluid (CSF) biomarkers and clinical diagnosis. Results: K114-labeled leukocytes exhibited distinctive fluorescent spectral signatures in MCI/AD subjects. Comparing subjects with single CSF biomarker-positive AD/MCI to negative controls, our technique yielded modest AUCs, which improved to the 0.90 range when only MCI subjects were included in order to measure performance in an early disease state. Combining CSF Aβ42 and t-Tau metrics further improved the AUC to 0.93. Conclusion: Our method holds promise for sensitive detection of AD-related protein misfolding in circulating leukocytes, particularly in the early stages of disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|